Skip to main content

prostate cancer Archives

My Southern Health: What to ask your doctor about prostate cancer screening

Jun. 28, 2018—In 2012, the United States Preventive Services Task Force recommended that men of all ages should not be routinely screened for levels of prostate-specific antigen (PSA). These are the blood tests to detect the possibility of prostate cancer. That group now recommends that men ages 55 to 69 should talk with their doctors and make well-informed individual decisions about the potential harms and benefits of PSA screening, and treatment if cancer is found.

Read more


Ingram sees recent cancer diagnosis as second chance

Apr. 19, 2018—“When it’s you, it’s a whole different feeling,” Orrin Ingram said, gazing at logs burning in the fireplace.

Read more


My Southern Health: What to ask your doctor about prostate cancer screening

May. 19, 2017—In 2012, the United States Preventive Services Task Force recommended that men of all ages should not be routinely screened for levels of prostate-specific antigen (PSA). That group now recommends that men ages 55 to 69 should talk with their doctors and make well-informed individual decisions about the potential harms and benefits of PSA screening, and treatment if cancer is found.

Read more


My Southern Health: What men should ask about prostate cancer screening

Apr. 24, 2017—In 2012, the United States Preventive Services Task Force recommended that men of all ages should not be routinely screened for levels of prostate-specific antigen (PSA). These are the blood tests to detect the possibility of prostate cancer.

Read more


Prostate cancer screening recommendations altered for some older men

Apr. 20, 2017—A federal task force has changed its recommendation about prostate cancer screening for some older men. The United States Preventive Services Task Force (USPSTF) now recommends that men between the ages of 55 to 69 consult with their physicians about getting routine screening blood tests to detect prostate cancer.

Read more


Study shows active surveillance preserves quality of life for prostate cancer patients

Mar. 21, 2017—Faced with the negative quality-of-life effects from surgery and radiation treatments for prostate cancer, low risk patients may instead want to consider active surveillance with their physician, according to a study released Tuesday by the Journal of the American Medical Association (JAMA).

Read more


New prostate cancer therapy investigated at VUMC

Sep. 22, 2016—Vanderbilt University Medical Center is the world’s first site to treat a patient in the TULSA-PRO Ablation Clinical Trial (TACT), which employs an emerging therapy that uses MRI guidance and robotically driven therapeutic ultrasound to obtain precise prostate cancer tissue ablation.

Read more


Prostate cancer survivors’ risk of heart disease studied

Feb. 4, 2016—The 3 million prostate cancer survivors in the United States are likely to die from something other than cancer, thanks to early detection, effective treatment and the disease’s slow progression.

Read more


‘Messages of Hope’ prostate cancer event is Dec. 11

Nov. 24, 2015—"Messages of Hope: Advances in Prostate Cancer Prevention, Research and Treatment," a free program for prostate cancer survivors, caregivers and health professionals, will be held Friday, Dec. 11, from 9 to 11 a.m. at the Vanderbilt-Ingram Cancer Center.

Read more


“Movember” activities help raise prostate cancer funds, awareness

Nov. 5, 2015—Beginning this week, Vanderbilt men will have a good excuse to ignore their razors and let their facial hair grow. November has been dubbed “Movember,” a time when men are encouraged to grow a moustache to raise funds and awareness for prostate cancer.

Read more


Vanderbilt-led study finds significant drop in new prostate cancer diagnoses

Jun. 18, 2015—A new study led by Vanderbilt University Medical Center investigators found new diagnoses of prostate cancer in the U.S. declined 28 percent in the year following the draft recommendation from the United States Preventive Services Task Force against routine PSA screening for men.

Read more


Grant bolsters Kirschner’s prostate cancer research

Feb. 5, 2015—Austin Kirschner, M.D., Ph.D., assistant professor of Radiation Oncology and Cancer Biology, has received the Urology Care Foundation Research Scholars Award for the study of advanced prostate cancer.

Read more


Upcoming Events

MORE EVENTS »